14.5EUR
121.30 MEUR
1.25 BEUR
4.12 M
About VIRBAC
Sector
Industry
CEO
Sébastien Huron
Website
Headquarters
Carros
Employees (FY)
5.46 K
Founded
1984
ISIN
FR0000031577
FIGI
BBG000BSSDN1
Virbac SA engages in the manufacture and sale of veterinary medicines. It operates through the following business segments: Companion Animals and Farm Animals. It develops vaccines, antibiotics, anesthetics, dermatological products, and drugs for pest control, inflammation, dental care, and ophthalmological conditions of pets and livestock. It also operates through the following geographical segments: France, Europe, Latin America, North America, Asia, Pacific, and Africa and Middle-East. The Europe segment excludes France. The company was founded by Pierre-Richard Dick and Max Rombi in 1968 and is headquartered in Carros, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of VIRP is 361.0 EUR — it has decreased by 1.50% in the past 24 hours. Watch VIRBAC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange VIRBAC stocks are traded under the ticker VIRP.
VIRP stock has risen by 0.84% compared to the previous week, the month change is a 1.12% rise, over the last year VIRBAC has showed a 15.52% increase.
We've gathered analysts' opinions on VIRBAC future price: according to them, VIRP price has a max estimate of 402.00 EUR and a min estimate of 311.00 EUR. Watch VIRP chart and read a more detailed VIRBAC stock forecast: see what analysts think of VIRBAC and suggest that you do with its stocks.
VIRP reached its all-time high on Nov 1, 2021 with the price of 448.5 EUR, and its all-time low was 5.5 EUR and was reached on Jun 4, 2001. View more price dynamics on VIRP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VIRP stock is 2.08% volatile and has beta coefficient of 0.68. Track VIRBAC stock price on the chart and check out the list of the most volatile stocks — is VIRBAC there?
Today VIRBAC has the market capitalization of 3.07 B, it has increased by 1.86% over the last week.
Yes, you can track VIRBAC financials in yearly and quarterly reports right on TradingView.
VIRP net income for the last quarter is 46.26 M EUR, while the quarter before that showed 75.04 M EUR of net income which accounts for −38.35% change. Track more VIRBAC financial stats to get the full picture.
Yes, VIRP dividends are paid annually. The last dividend per share was 1.32 EUR. As of today, Dividend Yield (TTM)% is 0.36%. Tracking VIRBAC dividends might help you take more informed decisions.
As of May 16, 2024, the company has 5.46 K employees. See our rating of the largest employees — is VIRBAC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VIRBAC EBITDA is 219.50 M EUR, and current EBITDA margin is 17.60%. See more stats in VIRBAC financial statements.
Like other stocks, VIRP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIRBAC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIRBAC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIRBAC stock shows the buy signal. See more of VIRBAC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.